Literature DB >> 20977365

Bile acid sequestrants: glucose-lowering mechanisms.

Janne Prawitt1, Bart Staels.   

Abstract

Bile acids are not only intestinal detergents, but also act as signaling molecules to control bile acid and metabolic homeostasis. By binding to the nuclear receptor farnesoid X receptor (FXR) or the membrane receptor TGR5, bile acids regulate lipid, glucose, and energy metabolism. The removal of bile acids from the enterohepatic cycle by orally administered sequestrants, nonabsorbable resins that complex bile acids in the intestinal lumen, is an effective treatment to reduce plasma cholesterol concentrations in dyslipidemia. In diabetic patients, sequestrants further lower hyperglycemia, and are thus useful in glycemic control. Here, we review the signaling pathways involved in the glucose-regulatory function of bile acids and our current understanding of the mechanisms behind the glucose-lowering effect of bile acid sequestrants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977365     DOI: 10.1089/met.2010.0096

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  7 in total

1.  Intestinal synthesis and secretion of bile salts as an adaptation to developmental biliary atresia in the sea lamprey.

Authors:  Chu-Yin Yeh; Yu-Wen Chung-Davidson; Huiyong Wang; Ke Li; Weiming Li
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

Review 2.  Bile acid metabolism and the pathogenesis of type 2 diabetes.

Authors:  Janne Prawitt; Sandrine Caron; Bart Staels
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

3.  Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer.

Authors:  Philip J Saylor; Edward D Karoly; Matthew R Smith
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531

4.  Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.

Authors:  Mohamed-Sami Trabelsi; Mehdi Daoudi; Janne Prawitt; Sarah Ducastel; Véronique Touche; Sama I Sayin; Alessia Perino; Cheryl A Brighton; Yasmine Sebti; Jérôme Kluza; Olivier Briand; Hélène Dehondt; Emmanuelle Vallez; Emilie Dorchies; Grégory Baud; Valeria Spinelli; Nathalie Hennuyer; Sandrine Caron; Kadiombo Bantubungi; Robert Caiazzo; Frank Reimann; Philippe Marchetti; Philippe Lefebvre; Fredrik Bäckhed; Fiona M Gribble; Kristina Schoonjans; François Pattou; Anne Tailleux; Bart Staels; Sophie Lestavel
Journal:  Nat Commun       Date:  2015-07-02       Impact factor: 14.919

5.  Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).

Authors:  Andreas Schmid; Hannah Neumann; Thomas Karrasch; Gerhard Liebisch; Andreas Schäffler
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 6.  Colon cancer checks in when bile acids check out: the bile acid-nuclear receptor axis in colon cancer.

Authors:  Qin Tang; Ronald M Evans
Journal:  Essays Biochem       Date:  2021-12-17       Impact factor: 8.000

Review 7.  Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy.

Authors:  D Dutta; S Kalra; M Sharma
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.